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A number of neurodegenerative diseases, among others
Alzheimer's disease (AD), are characterized by aggrega-
tion and accumulation of misfolded proteins. These pro-
tein aggregates are partly ubiquitinated. Tau protein,
which aggregates during AD, is poly-ubiquitinated in AD
brain to some extent.
In order to find modifiers of tau aggregation and post-
translational modification we screened for proteins,
which interact with tau protein. In previous experiments
we showed that the tau protein interacts with the protein
axotrophin of unkown function.
Affinity-purified antibodies against axotrophin C-termi-
nus labeled tau protein aggregates in AD brains.
Axotrophin harbours a C4HC3 zinc-finger-like motif in
the C-terminus, which is referred to as Ring-variant
domain and has been implicated in protein ubiquitina-
tion. Recombinant expression and refolding of the C-ter-
minus of axotrophin allowed us to test the E3-ubiquitin-
ligase activity. We found that axotrophin shows E3-ubiq-
uitin-ligase activity in combination with several E2
enzymes and becomes autoubiquitinated. Ubiquitination
of tau protein but not KLC1, another axotrophin-interact-
ing protein, was mediated by axotrophin.
Further investigation of ubiquitination effects on the pro-
tein tau will give more insights about the E3-ubiquitin-
ligase axotrophin and especially its role in AD.
from Annual Meeting of the Study Group Neurochemistry. International Conference of the Gesellschaft für Biochemie und Molekularbiologie 2006 (GBM 
2006): Molecular pathways in health and disease of the nervous system
Witten, Germany. 28–30 September 2006
Published: 23 March 2007
BMC Neuroscience 2007, 8(Suppl 1):P15 doi:10.1186/1471-2202-8-S1-P15
<supplement> <title> <p>Annual Meeting of the Study Group Neurochemistry. International Conference of the Gesellschaft für Biochemie und Molekularbiologie 2006 (GBM 2006): Molecular pathways in health and disease of the nervous system</p> </title> <editor>Christian Kaltschmidt, Barbara Kaltsch idt</editor  note>Meeting abstrac s – A single PDF containing all abstracts in this Suppl ment is availabl  <a href="www.biomedce tral.com/content/pdf/1471-2202-8-S1-full.pdf">here</a>.</note> <url>http://www.biomedcentral.com/content/pdf/1471-2202-8-S1-info.pdf</url> </supple-ment>
© 2007 Flach et al; licensee BioMed Central Ltd. 
